Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase II Study of Lenalidomide for the Treatment of Relapsed or Refractory Hodgkin's Lymphoma
This study has been completed.
Study NCT00478959   Information provided by University Health Network, Toronto

First Received on May 24, 2007.   Last Updated on July 14, 2015   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial